CRH Medical Corp (TSE:CRH)’s share price rose 1.1% on Friday . The company traded as high as C$2.89 and last traded at C$2.88. Approximately 190,337 shares were traded during mid-day trading, a decline of 57% from the average daily volume of 447,011 shares. The stock had previously closed at C$2.85.
CRH has been the subject of a number of research analyst reports. TD Securities reduced their target price on shares of CRH Medical from C$3.25 to C$2.50 and set a “hold” rating for the company in a research note on Monday, November 6th. National Bank Financial reduced their target price on shares of CRH Medical from C$5.25 to C$4.25 and set an “outperform” rating for the company in a research note on Monday, November 6th. Scotiabank cut their price target on shares of CRH Medical from C$6.00 to C$4.25 and set an “outperform” rating on the stock in a research report on Friday, November 3rd. Finally, Royal Bank of Canada cut their price target on shares of CRH Medical from C$5.00 to C$4.50 and set an “outperform” rating on the stock in a research report on Thursday, November 2nd. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. CRH Medical currently has a consensus rating of “Buy” and a consensus target price of C$3.88.
About CRH Medical
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
What are top analysts saying about CRH Medical? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CRH Medical and related companies.